Tag Archives: BPMC

Top Medical Stocks To Buy Right Now

Apollo Endosurgery (NASDAQ: APEN) and Arch Therapeutics (OTCMKTS:ARTH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

Valuation & Earnings

Get Apollo Endosurgery alerts:

This table compares Apollo Endosurgery and Arch Therapeutics’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Apollo Endosurgery $64.31 million 1.73 -$27.29 million ($2.01) -3.16
Arch Therapeutics N/A N/A -$7.78 million N/A N/A

Arch Therapeutics has lower revenue, but higher earnings than Apollo Endosurgery.

Top Medical Stocks To Buy Right Now: Otonomy, Inc.(OTIC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Otonomy Inc (NASDAQ:OTIC) has received a consensus rating of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $9.58.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Otonomy (OTIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Otonomy (OTIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Alkermes (NASDAQ: ALKS) and Otonomy (NASDAQ:OTIC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings.

  • [By Max Byerly]

    Otonomy (NASDAQ:OTIC) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.44) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.38) by ($0.06), Fidelity Earnings reports. The company had revenue of $0.12 million for the quarter, compared to the consensus estimate of $0.30 million. Otonomy had a negative net margin of 6,316.88% and a negative return on equity of 58.60%.

Top Medical Stocks To Buy Right Now: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on L3 Technologies (LLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of L3 Technologies (NYSE:LLL) have received a consensus recommendation of “Buy” from the fourteen analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $223.00.

  • [By Lou Whiteman]

    L-3 Technologies (NYSE:LLL) missed out on much of the rally enjoyed by other defense contractors over the last year. The reason for the lagging performance was because the company was in the middle of a transformation plan aimed at propelling it into the ranks of those larger rivals. Judging by its first-quarter results, the efforts are already beginning to show results.

  • [By Joseph Griffin]

    Sei Investments Co. lifted its stake in L3 Technologies Inc (NYSE:LLL) by 31.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,947 shares of the aerospace company’s stock after buying an additional 7,970 shares during the period. Sei Investments Co.’s holdings in L3 Technologies were worth $6,336,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    NEXT Financial Group Inc purchased a new position in shares of L3 Technologies Inc (NYSE:LLL) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 978 shares of the aerospace company’s stock, valued at approximately $203,000.

  • [By Joseph Griffin]

    Colony Group LLC lifted its holdings in shares of L3 Technologies Inc (NYSE:LLL) by 1.6% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 22,697 shares of the aerospace company’s stock after purchasing an additional 363 shares during the quarter. Colony Group LLC’s holdings in L3 Technologies were worth $4,365,000 as of its most recent filing with the Securities and Exchange Commission.

Top Medical Stocks To Buy Right Now: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top Medical Stocks To Buy Right Now: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on S&W Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on S&W Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

Top Medical Stocks To Buy Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Mutual of America Capital Management LLC acquired a new position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 10,500 shares of the biotechnology company’s stock, valued at approximately $667,000.

  • [By ]

    Blueprint Medicines (Nasdaq: BPMC), similarly to Loxo, is working on cancer medications that can target different mutations, and target them with precision. No wonder the stock rallied more than 14% this year, and that’s on top of the share-price more than doubling in the last three years. By 2020, BPMC plans to have two products already on the market, with four more pending. This company could certainly become a target for a larger peer, especially if its 2020 plan remains on track.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Blueprint Medicines (BPMC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

Top Medical Stocks To Buy Right Now: Costamare Inc.(CMRE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on COSTAMARE Inc/SH (CMRE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    COSTAMARE Inc/SH (NYSE:CMRE) has received an average recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $7.75.

  • [By Rich Smith]

    Shares of three big oceangoing container-shipping companies — Triton International (NYSE:TRTN), Seaspan (NYSE:SSW), and Costamare (NYSE:CMRE) — suffered huge losses in early trading Friday after Wells Fargo announced it was downgrading “the entire container complex,” as StreetInsider.com put it.

  • [By Logan Wallace]

    COSTAMARE Inc/SH (NYSE:CMRE) shares hit a new 52-week high during trading on Tuesday following a dividend announcement from the company. The stock traded as high as $8.15 and last traded at $8.10, with a volume of 15988 shares trading hands. The stock had previously closed at $7.98.

Top 10 Casino Stocks To Invest In 2019

Casinos and gaming suppliers are tripping over themselves to show how excited they are about the Supreme Court overturning a law that banned sports betting in every state in the U.S. except Nevada. Caesars Entertainment (NASDAQ:CZR), MGM Resorts (NYSE:MGM), and Scientific Games (NASDAQ:SGMS) all released statements in support of the potential of expanded sports betting with Scientific Games saying it could be the “greatest wave of gaming expansion in the United States in the past 20 years.” 

There’s no question that sports betting is already big business and legal sports betting is a big opportunity. But it could be years before laws are passed nationwide allowing for sports betting, and, as investors, we don’t know how the move will play out.

Image source: Getty Images.

The opportunity

Legalizing sports betting will bring an industry worth tens of billions of dollars per year out of the shadows of illegal betting, but it’s unclear just how big sportsbooks will be to casinos. The American Gaming Association estimates $150 billion is bet on sports per year, but that’s likely on the high side of the opportunity. Jay Zagorsky recently wrote that the sports betting industry would be about $67 billion if it matches the level of play that the U.K. does per person.

Top 10 Casino Stocks To Invest In 2019: Aerosonic Corporation(AIM)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Aimia Inc (TSE:AIM) have earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1 year price target among brokers that have covered the stock in the last year is C$3.54.

  • [By Shane Hupp]

    Aimia (TSE:AIM) has earned an average rating of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is C$2.67.

Top 10 Casino Stocks To Invest In 2019: Harmonic Inc.(HLIT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Harmonic (NASDAQ: HLIT) and Commscope (NASDAQ:COMM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Harmonic (HLIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Harmonic (NASDAQ:HLIT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Thursday.

Top 10 Casino Stocks To Invest In 2019: Sherwin-Williams Company (SHW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News articles about Sherwin-Williams (NYSE:SHW) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Sherwin-Williams earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave media stories about the specialty chemicals company an impact score of 46.7658649972856 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Dan Caplinger]

    Investors like dividend stocks that aren’t stingy with their payouts. Yet even among the elite ranks of the Dividend Aristocrats — stocks that have increased their annual payments to shareholders for at least 25 straight years — you can find some companies with dividend yields that are embarrassingly low. Below, we’ll look more closely at Roper Technologies (NYSE:ROP), S&P Global (NYSE:SPGI), and Sherwin-Williams (NYSE:SHW) to see why they give investors a somewhat mixed picture when it comes to dividends.

  • [By Shane Hupp]

    United Capital Financial Advisers LLC grew its position in Sherwin-Williams Co (NYSE:SHW) by 22.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,669 shares of the specialty chemicals company’s stock after purchasing an additional 498 shares during the quarter. United Capital Financial Advisers LLC’s holdings in Sherwin-Williams were worth $1,047,000 as of its most recent SEC filing.

  • [By Motley Fool Transcribing]

    Sherwin-Williams (NYSE:SHW) Q4 2018 Earnings Conference CallJan. 31, 2019 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Sherwin-Williams Co (NYSE:SHW) SVP Jane M. Cronin sold 858 shares of the firm’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $443.16, for a total transaction of $380,231.28. Following the completion of the transaction, the senior vice president now directly owns 3,257 shares in the company, valued at $1,443,372.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Sherwin-Williams (SHW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In 2019: American Capital Mortgage Investment Corp.(MTGE)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of MTGE Investment (NASDAQ:MTGE) from a hold rating to a buy rating in a research note published on Thursday.

    A number of other brokerages have also weighed in on MTGE. Keefe, Bruyette & Woods lowered shares of MTGE Investment from an outperform rating to a market perform rating in a research report on Monday, May 7th. Maxim Group lowered shares of MTGE Investment from a buy rating to a hold rating and cut their target price for the company from $21.00 to $19.75 in a research report on Friday, May 4th. Finally, ValuEngine lowered shares of MTGE Investment from a buy rating to a hold rating in a research report on Wednesday, May 2nd.

Top 10 Casino Stocks To Invest In 2019: Finjan Holdings, Inc.(FNJN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Finjan alerts:

    You Need To Taste These: Finjan Holdings, Inc. (NASDAQ:FNJN), The Dixie Group, Inc. (NASDAQ:DXYN), Sky Solar … (thestreetpoint.com) With a 125/250 Day Adjusted Slope of 63.35003, Is Finjan Holdings, Inc. (NasdaqCM:FNJN) a Favorable Pick? (cantoncaller.com) Which Option is Best? Finjan Holdings, Inc. (FNJN) Buy or Sell (topdesertsafari.com) Finjan Holdings Inc (FNJN) Given Average Recommendation of “Strong Buy” by Analysts (americanbankingnews.com)

    Several research analysts recently issued reports on the stock. TheStreet raised shares of Finjan from a “c+” rating to a “b-” rating in a report on Tuesday, August 14th. Dawson James reissued a “buy” rating on shares of Finjan in a report on Tuesday, May 22nd. Finally, ValuEngine cut shares of Finjan from a “buy” rating to a “hold” rating in a report on Thursday, August 2nd.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By Max Byerly]

    Digital Turbine (NASDAQ: FNJN) and Finjan (NASDAQ:FNJN) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In 2019: PGT, Inc.(PGTI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Griffon (NYSE:GFF) and PGT Innovations (NYSE:PGTI) are both small-cap multi-sector conglomerates companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PGT Innovations (PGTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    There is also a boost to windows, doors, and roofing. JELD-WEN Holding, Inc. (NYSE: JELD) was up 2.4% at $26.05 late on Tuesday, but that is a gain of over 5% from last Friday for the doors and windows maker. PGI Innovations, Inc. (NASDAQ: PGTI) had been up as high as $26.40 earlier on Tuesday, but the last look of being down 1% at $25.95 was still up over 2% from last Friday.

  • [By Ethan Ryder]

    Systematic Financial Management LP grew its holdings in PGT Innovations Inc (NYSE:PGTI) by 9.9% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 309,950 shares of the construction company’s stock after buying an additional 28,000 shares during the period. Systematic Financial Management LP owned 0.61% of PGT Innovations worth $6,462,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    News coverage about PGT Industries (NYSE:PGTI) has trended somewhat positive recently, Accern reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. PGT Industries earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news stories about the construction company an impact score of 45.4754593412205 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Shane Hupp]

    Griffon (NYSE:GFF) and PGT Innovations (NYSE:PGTI) are both small-cap multi-sector conglomerates companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Top 10 Casino Stocks To Invest In 2019: Guggenheim S&P MidCap 400 Pure Gr ETF (RFG)

Advisors’ Opinion:

  • [By Max Byerly]

    Invesco S&P MidCap 400 Pure Growth ETF (NYSEARCA:RFG) announced a quarterly dividend on Monday, September 24th, Wall Street Journal reports. Investors of record on Tuesday, September 25th will be given a dividend of 0.5521 per share on Friday, September 28th. This represents a $2.21 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Monday, September 24th. This is a boost from Invesco S&P MidCap 400 Pure Growth ETF’s previous quarterly dividend of $0.26.

Top 10 Casino Stocks To Invest In 2019: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Citrix Systems alerts:

    Citrix Systems (CTXS) VP Jessica Soisson Sells 3,281 Shares (americanbankingnews.com) Glancy Prongay & Murray LLP Continues Investigation on Behalf of Citrix Systems, Inc. (CTXS) Investors (bizjournals.com) Glancy Prongay & Murray LLP Continues Investigation on Behalf of Citrix Systems, Inc. (CTXS) Investors (markets.financialcontent.com) Citrix Michael Lewis Day 3 Highlights from Synergy 2018 (dabcc.com) Citrix Certification Guide: Overview and Career Paths (businessnewsdaily.com)

    A number of brokerages have commented on CTXS. Mizuho reaffirmed a “buy” rating on shares of Citrix Systems in a report on Wednesday, May 9th. Zacks Investment Research raised Citrix Systems from a “hold” rating to a “strong-buy” rating and set a $118.00 price objective on the stock in a report on Tuesday, May 1st. Goldman Sachs raised Citrix Systems from a “buy” rating to a “conviction-buy” rating in a report on Tuesday, May 1st. Royal Bank of Canada upped their price objective on Citrix Systems to $104.00 and gave the company a “market perform” rating in a report on Thursday, April 26th. Finally, Barclays upped their price objective on Citrix Systems from $90.00 to $100.00 and gave the company an “equal weight” rating in a report on Thursday, April 26th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, six have given a buy rating and three have given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $102.31.

  • [By VantagePoint]

    Citrix Systems, Inc. (NASDAQ: CTXS) had a very clear crossover to the upside on April 11, and since that day's close the stock is up 15 percent. This one is interesting also because the two moving averages have also recently diverged even further, indicating that the uptrend has only gotten stronger since the company posted an excellent Q1 earnings and Q2 guidance report that came in well above Wall Street's expectations. 

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Citrix Systems (CTXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Citrix Systems (CTXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Northern Trust Corp boosted its position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 0.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 497,135 shares of the biotechnology company’s stock after acquiring an additional 726 shares during the period. Northern Trust Corp owned 1.13% of Blueprint Medicines worth $45,588,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

Top 10 Casino Stocks To Invest In 2019: Eagle Bulk Shipping Inc.(EGLE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Several brokerages have updated their recommendations and price targets on shares of Eagle Bulk Shipping (NASDAQ: EGLE) in the last few weeks:

    7/2/2018 – Eagle Bulk Shipping was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating. 6/28/2018 – Eagle Bulk Shipping was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 6/18/2018 – Eagle Bulk Shipping is now covered by analysts at Morgan Stanley. They set an “equal weight” rating and a $6.50 price target on the stock. 6/18/2018 – Eagle Bulk Shipping is now covered by analysts at DNB Markets. They set a “buy” rating on the stock. 6/12/2018 – Eagle Bulk Shipping was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 6/2/2018 – Eagle Bulk Shipping was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating. 6/2/2018 – Eagle Bulk Shipping was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating. 5/29/2018 – Eagle Bulk Shipping is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $7.50 price target on the stock. 5/15/2018 – Eagle Bulk Shipping was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Eagle Bulk Shipping is the largest U.S. based owner of Handymax dry bulk vessels. Handymax dry bulk vessels range in size from 35,000 to 60,000 deadweight tons, or dwt, and transport a broad range of major and minor bulk cargoes, including iron ore, coal, grain, cement and fertilizer, along worldwide shipping routes. “ 5/9/2018 – Eagle Bulk Shipping had its “hold” rating reaffirmed by analysts at Maxim Group. They now have a $6.00 price target on the

  • [By Joseph Griffin]

    Eagle Bulk Shipping Inc. (NASDAQ:EGLE) major shareholder Goldentree Asset Management Lp acquired 84,969 shares of the business’s stock in a transaction on Monday, February 11th. The shares were bought at an average cost of $4.02 per share, for a total transaction of $341,575.38. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Top 10 Heal Care Stocks To Buy For 2019

AmeriCold Realty Trust (NYSE: ORC) and Orchid Island Capital (NYSE:ORC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

Earnings & Valuation

Get AmeriCold Realty Trust alerts:

This table compares AmeriCold Realty Trust and Orchid Island Capital’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AmeriCold Realty Trust $1.54 billion 2.22 -$600,000.00 N/A N/A
Orchid Island Capital $145.96 million 2.82 $2.00 million $0.84 9.42

Orchid Island Capital has lower revenue, but higher earnings than AmeriCold Realty Trust.

Top 10 Heal Care Stocks To Buy For 2019: Terra Nitrogen Company L.P.(TNH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Evogene (NASDAQ: EVGN) and Terra Nitrogen (NYSE:TNH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

  • [By Logan Wallace]

    Media stories about Terra Nitrogen (NYSE:TNH) have been trending somewhat negative this week, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Terra Nitrogen earned a news impact score of -0.02 on Accern’s scale. Accern also gave news articles about the basic materials company an impact score of 46.8553415416776 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Heal Care Stocks To Buy For 2019: Lexington Realty Trust(LXP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Lexington Realty Trust (NYSE:LXP) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 8th. Analysts expect Lexington Realty Trust to post earnings of $0.06 per share for the quarter. Lexington Realty Trust has set its FY18 guidance at $0.95-0.98 EPS.

  • [By Logan Wallace]

    TRADEMARK VIOLATION NOTICE: “Lexington Realty Trust (LXP) Scheduled to Post Quarterly Earnings on Wednesday” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/4164994/lexington-realty-trust-lxp-scheduled-to-post-quarterly-earnings-on-wednesday.html.

  • [By Ethan Ryder]

    Wells Fargo & Co upgraded shares of Lexington Realty Trust (NYSE:LXP) from a market perform rating to an outperform rating in a research note issued to investors on Thursday, MarketBeat.com reports. Wells Fargo & Co currently has $9.00 target price on the real estate investment trust’s stock, up from their prior target price of $8.50.

  • [By Ethan Ryder]

    Lexington Realty Trust (NYSE:LXP) was downgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, MarketBeat reports. They currently have a $7.00 target price on the real estate investment trust’s stock, down from their previous target price of $8.50. Stifel Nicolaus’ price target suggests a potential downside of 15.66% from the stock’s current price.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Lexington Realty Trust (LXP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Lexington Realty Trust (LXP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Buy For 2019: Briggs & Stratton Corporation(BGG)

Advisors’ Opinion:

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Todd Teske, chairman, president and CEO of Briggs & Stratton (BGG) , the small-engine maker that posted a penny-a-share earnings beat on Wednesday, but saw shares fall 11% on lighter-than-expected revenues and a cut in the company’s full-year guidance.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday.
    SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results.
    Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance.
    New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results.
    Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash.
    China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday.
    Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results.
    eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results.
    Southw

  • [By Garrett Baldwin]

    By submitting your email address you will receive a free subscription to Profit Alerts and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

    Three Stocks to Watch Today: CSCO, M, BLK
    The earnings report calendar is headlined today by Cisco Systems Inc. (Nasdaq: CSCO). The tech giant will report fiscal fourth-quarter earnings after the bell. Wall Street expects that the firm will report earnings per share (EPS) of $0.69 on top of $12.77 billion in revenue. Shares of Macy’s Inc. (NYSE: M) are on the move after the company reported earnings before the bell. The iconic retailer reported adjusted EPS of $0.70 on top of $5.57 billion in revenue. Wall Street had expected EPS of $0.49 on top of $5.61 billion in revenue. Shares of Macy’s stock were off 5.3% in premarket hours. George Soros’ firm Soros Fund Management increased its stake in shares of Blackrock Inc. (NYSE: BLK) by a whopping 60% in the second quarter, according to a U.S. Securities and Exchange Commission (SEC) filing. If you were using Money Morning’s proprietary Stock VQScore™, you’d have known that Blackrock was sitting in the “Buy Zone” before the SEC filing was made public. The global asset manager has a perfect 4.75 score, and it will look to blast off now that other investors start to follow Soros and other institutional investors that love this stock. To learn more about the Money Morning Stock VQScore, go here right now. Look for additional earnings reports from NetApp Inc. (Nasdaq: NTAP), MSG Networks Inc. (NYSE: MSGN), CACI International Inc. (NYSE: CACI), Briggs & Stratton Corp. (NYSE: BGG), SpartanNash Co. (Nasdaq: SPTN), and Luxoft Holding Inc. (NYSE: LXFT).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Motley Fool Transcriber]

    Briggs & Stratton Corporation (NYSE: BGG)Q4 2018 Briggs & Stratton Corp Earnings CallAug. 16, 2018, 2 p.m. EDT

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Jon C. Ogg]

    Generac Holdings Inc. (NYSE: GNRC) was up less than 1% at $59.20 late on Tuesday, but that is actually up by over 6% from last Friday’s close for the generator maker before the storm threat was so imminent. Briggs & Stratton Corp. (NYSE: BGG) is also in that field and its gain of just 0.3% to $20.45 late on Tuesday was actually up only about 1% from last Friday as the company is more diversified

Top 10 Heal Care Stocks To Buy For 2019: GlobalSCAPE, Inc.(GSB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Akorn, Inc. (NASDAQ: AKRX) fell 32.7 percent to $13.25 in pre-market trading after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 15.7 percent to $12.30 in pre-market trading. Subsea 7 confirmed a $7.00 per share proposal to acquire Mcdermott, pending termination of merger agreement with CB&I.
    Myomo, Inc. (NYSE: MYO) fell 9 percent to $3.65 in pre-market trading after rising 11.39 percent on Friday.
    Hasbro, Inc. (NASDAQ: HAS) fell 8 percent to $88.36 in pre-market trading after the company reported weaker-than-expected results for its first quarter on Monday.
    SunPower Corporation (NASDAQ: SPWR) fell 7.1 percent to $9.00 in pre-market trading.
    Endeavour Silver Corp. (NYSE: EXK) shares fell 5.9 percent to $2.88 in pre-market trading after declining 3.16 percent on Friday.
    Mattel, Inc. (NASDAQ: MAT) shares fell 5.5 percent to $12.25 in pre-market trading.
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares fell 5.1 percent to $2.96 in pre-market trading after rising 76.27 percent on Friday.
    GlobalSCAPE, Inc. (NYSE: GSB) fell 5.1 percent to $3.57 in pre-market trading.
    Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) shares fell 4.1 percent to $49.93 in pre-market trading.
    Oasis Petroleum Inc. (NYSE: OAS) fell 4.1 percent to $9.75 in pre-market trading. SunTrust Robinson Humphrey downgraded Oasis Petroleum from Hold to Sell

Top 10 Heal Care Stocks To Buy For 2019: Western Asset Municipal Partners Fund, Inc.(MNP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Fiera Capital Corp grew its holdings in shares of Western Asset Municipal Partners Fnd Inc (NYSE:MNP) by 46.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 196,895 shares of the financial services provider’s stock after purchasing an additional 62,761 shares during the quarter. Fiera Capital Corp’s holdings in Western Asset Municipal Partners Fnd were worth $2,780,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Media stories about Western Asset Municipal Partners Fnd (NYSE:MNP) have been trending positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Western Asset Municipal Partners Fnd earned a media sentiment score of 0.38 on Accern’s scale. Accern also assigned media headlines about the financial services provider an impact score of 46.9266470312802 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 Heal Care Stocks To Buy For 2019: Suzuki Motor Corporation (SZKMY)

Advisors’ Opinion:

  • [By ]

    Suzuki Motor Corp. [TYO: 7269] (OTCPK:SZKMY) (OTCPK:SZKMF)

    On September 7 The Times of India reported: “Suzuki to start testing electric vehicle prototypes in India. Suzuki would launch EVs in India around 2020 in cooperation.”

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on SUZUKI MTR CORP/ADR (SZKMY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Buy For 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    After reporting second-quarter financial results and updating investors on the progress it’s making in developing cancer therapies targeting specific genetic mutations, Blueprint Medicines (NASDAQ:BPMC) saw its shares rocket 17% yesterday. News that management is initiating new trials and potentially filing its first drug for FDA approval in 2019 helped spark investors’ interest, but that wasn’t the only thing management said about its future. Read on to learn more about this clinical-stage biotech stock and whether it’s right for your portfolio.

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By ]

    Blueprint Medicines (Nasdaq: BPMC), similarly to Loxo, is working on cancer medications that can target different mutations, and target them with precision. No wonder the stock rallied more than 14% this year, and that’s on top of the share-price more than doubling in the last three years. By 2020, BPMC plans to have two products already on the market, with four more pending. This company could certainly become a target for a larger peer, especially if its 2020 plan remains on track.

  • [By Ethan Ryder]

    Mutual of America Capital Management LLC acquired a new position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 10,500 shares of the biotechnology company’s stock, valued at approximately $667,000.

  • [By Ethan Ryder]

    Shares of Blueprint Medicines Corp (NASDAQ:BPMC) have received an average recommendation of “Buy” from the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $92.22.

Top 10 Heal Care Stocks To Buy For 2019: Pacific Gas & Electric Co.(PCG)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Many major utilities are now ramping up investments in cost-saving, margin-boosting energy efficiency programs. In fact, there’s a strong correlation between the most ambitious renewable energy investment strategies and energy efficiency programs. Some utilities have a lot of catching up to do.  

    Xcel Energy (NASDAQ:XEL) has saved 13,000 GWh of electricity consumption across its network over the years, including 9,000 GWh since 2005. The company has an ambitious plan to retire coal-fired power plants and build new wind and solar power capacity, which, when coupled with energy efficiency, could allow it to generate 45% of its electricity from renewables in 2027. Additionally, fuel-related expenses would drop from 47% of capital investments in 2010 to just 28% in 2027. That would free up more cash flow for dividends or growth projects — or both. PG&E (NYSE:PCG) recently filed a plan to retire an aging fossil fuel power plant with distributed solar and energy efficiency programs, as discussed on a recent quarterly conference call with investors. The utility also offers some of the most ambitious customer rebates in the country, with up to $5,500 per household. Southern Company (NYSE:SO) has saved 2,700 GWh of electricity consumption across its network since 2000. By 2020, it will have invested $1 billion total in energy efficiency programs, although that lags well behind more ambitious peers. Dominion Energy (NYSE:D) was ranked second to last among all utilities in the country in energy efficiency by the American Council for an Energy Efficient Economy. That leaves plenty of room for improvement. A recent report suggests it’s possible to reduce new home energy consumption in Virginia (the company’s home state) by 60%, saving the utility billions in capital investments in the next decade by avoiding the need to build new facilities. Those efforts could also save customers $1.7 billion, but the utility’s most recent plan does not prioritize energy efficien

  • [By Logan Wallace]

    Pacific Gas and Electric (NYSE: PCG) and Unitil (NYSE:UTL) are both utilities companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

  • [By Jon C. Ogg]

    PG&E Corp. (NYSE: PCG), the parent of Pacific Gas & Electric, has been the focus of many regulatory actions in California over time. And power lines have been targeted, and PG&E shares dropped after the 2017 wildfires in the state.

  • [By Logan Wallace]

    Northern Trust Corp cut its stake in PG&E Co. (NYSE:PCG) by 0.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,920,440 shares of the utilities provider’s stock after selling 44,939 shares during the period. Northern Trust Corp owned approximately 1.14% of PG&E worth $251,974,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Tyler Crowe, Matthew Frankel, CFP, and Neha Chamaria]

    So we asked three Motley Fool contributors to each highlight a stock that has caught the eye of billionaire hedge funds, why they are buying, and why you might want to consider doing the same. Here’s why they picked United Technologies (NYSE:UTX), PG&E (NYSE:PCG), and Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B).

  • [By Ethan Ryder]

    Commonwealth Bank of Australia decreased its position in PG&E Co. (NYSE:PCG) by 11.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,648,065 shares of the utilities provider’s stock after selling 586,715 shares during the quarter. PG&E accounts for approximately 2.0% of Commonwealth Bank of Australia’s holdings, making the stock its 12th largest holding. Commonwealth Bank of Australia owned 0.90% of PG&E worth $200,489,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Buy For 2019: Jersey Elec.(a)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rampart Investment Management Company LLC grew its stake in shares of Agilent Technologies Inc (NYSE:A) by 26.3% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 28,467 shares of the medical research company’s stock after buying an additional 5,936 shares during the period. Rampart Investment Management Company LLC’s holdings in Agilent Technologies were worth $1,760,000 as of its most recent filing with the SEC.

  • [By Michael Bloom]

    RBC’s Mark Mahaney said in his earnings recap note, “Amazon traded off 5% in the aftermarket because: a)
    it was a Modest Beat & Mixed Quarter AND stock was up 14% YTD (3% yesterday), implying high expectations; b) cautious Q&A commentary around impact of potential India regulations; & c) commentary suggesting ’19 would see step-up in investment spend…That said, we view the Amazon Long Thesis as Very Well Intact.”

  • [By Ethan Ryder]

    Shares of Agilent Technologies (NYSE:A) fell 9.7% during trading on Tuesday . The company traded as low as $60.70 and last traded at $62.50. 14,450,244 shares changed hands during mid-day trading, an increase of 458% from the average session volume of 2,590,339 shares. The stock had previously closed at $69.21.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Agilent Technologies, Inc. (NYSE: A) which traded down about 10% at $62.51. The stock’s 52-week range is $55.60 to $75.00. Volume was 14 million compared to the daily average volume of 2.6 million.

Top 10 Heal Care Stocks To Buy For 2019: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    Taiwan Semiconductor Manufacturing Company (NYSE:TSM), or TSMC for short, is one of Apple’s (NASDAQ:AAPL) most important suppliers. The company has manufactured Apple’s A-series chips starting with the A8 and continuing through to today’s A12 Bionic chip and has been the exclusive manufacturer of all but one of those chips — the A9.

  • [By Ashraf Eassa]

    The claim from Intel seems questionable at best. To illustrate, let’s dive deep into when Intel has brought products to market on new technologies and when its competition — Taiwan Semiconductor Manufacturing Company (NYSE:TSM) and Samsung (NASDAQOTH:SSNLF) — have. 

  • [By ]

    AMD’s comments come amid growing concerns that a slowdown in cryptocurrency mining activity (following a slump in crypto prices) could lead disillusioned miners to flood the market with used graphics cards. Last week, top chip foundry Taiwan Semiconductor (TSM) , which counts AMD, Nvidia  (NVDA) and leading crypto mining ASIC developer Bitmain as clients, cautioned that there’s “uncertainty” surrounding second-half crypto demand. AMD believes miners accounted for about 10% of its Q1 sales.

Hot Value Stocks To Watch Right Now

This article began by searching for stocks hitting their 52-week low. DHI Group (NYSE:DHX) reached its 52-week low on Monday, April 3, 2017. At $3.90 it offered investors value. Then the stock moved up over the next few days as I prepared this article. DHX closed Friday, April 7, 2017, at $4.50.

DHI Group is a micro-cap with historical and impressive, consistent high FCF margins that the market forgot. Revenue growth challenges from a difficult specialized job market and increased competition (mostly perceived) chased away the original shareholder base of magic formula growth investors. This overlooked investment has an asset light business model that consistently generates the staffing industry’s highest FCF yields. Coupled with its aggressive, opportunistic share buybacks, debt reduction and activist interest, the stock offers longer-term value investors a tempting opportunity.

Profile

DHI Group offers employment related professional connections through several specialized job recruitment websites. Additionally, their software services access, search and analyze their proprietary resume databases. These targeted professionals work within technology, financial services, energy, healthcare and the hospitality industries. Above all, the goal is to allow professionals and organizations to access proprietary data to compete for employment connections. Employers and recruiters use their websites and services to find the most qualified professionals within their skilled occupations. Individual professionals use their websites and services to find the best jobs, industry news, detailed salary information, and expand networking opportunities.

Hot Value Stocks To Watch Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By ]

    Blueprint Medicines (Nasdaq: BPMC), similarly to Loxo, is working on cancer medications that can target different mutations, and target them with precision. No wonder the stock rallied more than 14% this year, and that’s on top of the share-price more than doubling in the last three years. By 2020, BPMC plans to have two products already on the market, with four more pending. This company could certainly become a target for a larger peer, especially if its 2020 plan remains on track.

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Leerink Swann began coverage on shares of Blueprint Medicines (NASDAQ:BPMC) in a research note released on Tuesday morning, Marketbeat Ratings reports. The firm issued an outperform rating and a $105.00 target price on the biotechnology company’s stock. Leerink Swann also issued estimates for Blueprint Medicines’ Q3 2018 earnings at ($1.63) EPS, Q4 2018 earnings at ($1.72) EPS, FY2018 earnings at ($5.26) EPS, FY2019 earnings at ($6.78) EPS, FY2020 earnings at ($6.38) EPS, FY2021 earnings at ($1.53) EPS and FY2022 earnings at $4.15 EPS.

Hot Value Stocks To Watch Right Now: Ternium S.A.(TX)

Advisors’ Opinion:

  • [By Max Byerly]

    TransferCoin (TX) is a PoW/PoS coin that uses the Proof of Stake hashing algorithm. It was first traded on August 11th, 2015. TransferCoin’s total supply is 6,660,351 coins. The official message board for TransferCoin is transfercointx.pw. The Reddit community for TransferCoin is /r/TXPRJ and the currency’s Github account can be viewed here. TransferCoin’s official Twitter account is @Transfer_dev. The official website for TransferCoin is txproject.io.

  • [By Joseph Griffin]

    TransferCoin (CURRENCY:TX) traded down 3.4% against the U.S. dollar during the 24 hour period ending at 22:00 PM E.T. on September 10th. Over the last week, TransferCoin has traded down 36% against the U.S. dollar. TransferCoin has a market capitalization of $1.44 million and $52,523.00 worth of TransferCoin was traded on exchanges in the last day. One TransferCoin coin can now be bought for $0.22 or 0.00003424 BTC on major exchanges including Bittrex, Livecoin, Cryptopia and YoBit.

  • [By Max Byerly]

    Ternium SA (NYSE:TX) has received a consensus recommendation of “Hold” from the seven research firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $39.50.

Hot Value Stocks To Watch Right Now: Statoil ASA(STO)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Another highlight in April was that Shell gave the green light to the Vito project, which is a joint venture with Statoil (NYSE:STO) in the Gulf of Mexico. Shell and Statoil were able to cut that project’s cost estimate by 70% from the original design so that it’s now profitable at $35 a barrel. The partners expect the project to produce 100,000 BOE/D of low-cost oil and gas when it comes online in 2021.

  • [By Tyler Crowe]

    Anyone that has watched oil prices tick up recently has probably expected oil producers to report some impressive earnings results this past quarter, and Statoil (NYSE:STO) did just that with a 21% boost to the bottom line. At the same time, management is using all of its additional cash to do some wheeling and dealing that should help boost its growth possibilities in the nearer term.

  • [By Shane Hupp]

    Statoil (NYSE: STO) and Delek US (NYSE:DK) are both oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, dividends, profitability and risk.

Hot Value Stocks To Watch Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By Ethan Ryder]

    Akamai Technologies, Inc. (NASDAQ:AKAM)’s share price reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $81.46 and last traded at $81.47, with a volume of 38096 shares traded. The stock had previously closed at $81.23.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund]

    Content distribution specialist Akamai Technologies (NASDAQ:AKAM) has seen its shares surge 52% in 2018, powered by a string of solid earnings surprises. Does this bottle rocket have any fuel left to burn, or should Akamai investors brace themselves for an upcoming correction?

Hot Clean Energy Stocks To Invest In 2019

Natural gas for transportation leader Clean Energy Fuels Corp (NASDAQ:CLNE) has steadily grown and improved the quality of its business and business results over the past several years. Today’s Clean Energy Fuels is leaner, has a stronger balance sheet, and is in a solid position as a market leader in a growth industry.

But is the stock undervalued? By one metric, book value per share, it looks downright cheap. But management used a massive amount of stock to make ends meet over the past 18 months, destroying a significant amount of shareholder value in the process. Still, the loss of an important tax credit will have multimillion-dollar implications, and the sale of a very profitable part of the business raises questions about the company’s ability to generate positive cash flows this year.

Image source: Getty Images.

Hot Clean Energy Stocks To Invest In 2019: Sterling Construction Company Inc(STRL)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Lisa Levin] Gainers
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 50.7 percent to $4.34 after the company announced a special $1.00 per share cash dividend.
    Impinj, Inc. (NASDAQ: PI) surged 28.4 percent to $17.44 after reporting Q1 results.
    Cardlytics, Inc. (NASDAQ: CDLX) gained 22 percent to $17.945.
    Care.com, Inc. (NYSE: CRCM) shares rose 19.3 percent to $18.92 following Q1 earnings.
    Sharing Economy International Inc. (NASDAQ: SEII) jumped 19.1 percent to $4.3934 after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Blink Charging Co. (NASDAQ: BLNK) rose 18.6 percent to $4.79 after jumping 171.14 percent on Monday.
    IntriCon Corporation (NASDAQ: IIN) climbed 17.4 percent to $29.30 after reporting Q1 results.
    Nevsun Resources Ltd. (NYSE: NSU) rose 16.2 percent to $3.45 after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Tactile Systems Technology, Inc. (NASDAQ: TCMD) gained 15.4 percent to $42.61 following Q1 results.
    eGain Corporation (NASDAQ: EGAN) gained 15.3 percent to $10.55 following Q3 earnings.
    Dean Foods Company (NYSE: DF) rose 13.8 percent to $9.48 after reporting upbeat Q1 earnings.
    Sterling Construction Company, Inc. (NASDAQ: STRL) shares surged 13.1 percent to $13.42 after reporting Q1 results.
    USA Technologies, Inc. (NASDAQ: USAT) climbed 11.9 percent to $10.85 following better-than-expected Q3 earnings.
    scPharmaceuticals Inc. (NASDAQ: SCPH) gained 11.2 percent to $14.45 following Q1 results.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 10.2 percent to $24.08 following Q1 results.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 7.9 percent to $19.60 as the company posted upbeat Q1 results and raised its outlook.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 7.7 percent to $11.90 following upbeat Q1 results.
    Pareteum Corporation (NASDAQ: TEUM) rose 6.8 perc
  • [By Lisa Levin]

    Tuesday afternoon, the industrial shares rose 0.73 percent. Meanwhile, top gainers in the sector included Yangtze River Port and Logistics Limited (NASDAQ: YRIV), up 28 percent, and Sterling Construction Company, Inc. (NASDAQ: STRL) up 15 percent.

  • [By Logan Wallace]

    Sterling Construction Company Inc (NASDAQ:STRL) – Equities research analysts at DA Davidson lowered their Q3 2018 earnings per share estimates for Sterling Construction in a research note issued to investors on Tuesday, May 8th. DA Davidson analyst B. Thielman now anticipates that the construction company will earn $0.37 per share for the quarter, down from their prior forecast of $0.38. DA Davidson also issued estimates for Sterling Construction’s Q4 2018 earnings at $0.21 EPS.

Hot Clean Energy Stocks To Invest In 2019: Newcastle Investment Corporation(NCT)

Advisors’ Opinion:

  • [By Shane Hupp]

    PolySwarm (CURRENCY:NCT) traded 5.6% lower against the U.S. dollar during the 1-day period ending at 22:00 PM E.T. on July 4th. One PolySwarm token can now be purchased for $0.0039 or 0.00000059 BTC on major cryptocurrency exchanges including HitBTC, IDEX and DDEX. During the last seven days, PolySwarm has traded 8.4% higher against the U.S. dollar. PolySwarm has a total market cap of $5.94 million and $28,632.00 worth of PolySwarm was traded on exchanges in the last day.

  • [By Joseph Griffin]

    PolySwarm (CURRENCY:NCT) traded 3.5% lower against the dollar during the 1 day period ending at 0:00 AM Eastern on June 2nd. PolySwarm has a market cap of $9.94 million and $67,420.00 worth of PolySwarm was traded on exchanges in the last 24 hours. One PolySwarm token can currently be purchased for $0.0068 or 0.00000089 BTC on major exchanges including HitBTC, DDEX and IDEX. In the last week, PolySwarm has traded 8.2% lower against the dollar.

Hot Clean Energy Stocks To Invest In 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Todd Campbell]

    In this clip of The Motley Fool’s Industry Focus Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to discuss LOXO-292’s opportunity and how competitor Blueprint Medicines (NASDAQ:BPMC) is challenging it. Also, the two analysts discuss why shares in Abiomed, Inc. (NASDAQ:ABMD) are soaring higher and if this is a high-priced stock that investors should embrace or ignore.

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

Hot Clean Energy Stocks To Invest In 2019: Westport Innovations Inc(WPRT)

Advisors’ Opinion:

  • [By Daniel Miller]

    Shares of Westport Fuel Systems (NASDAQ:WPRT), a provider of high-performance, low-emission engine and fuel systems, are down 10% as of 11:20 a.m. EDT after the company reported its first-quarter results.

  • [By Maxx Chatsko]

    Shares of Westport Fuel Systems (NASDAQ:WPRT) jumped 11.9% last month, according to data provided by S&P Global Market Intelligence. But it wasn’t a smooth ride for shareholders.

  • [By Dan Caplinger]

    Friday was a relatively quiet day on Wall Street, with a split among the most widely followed market benchmarks that sent some up and others down. Slight downticks in oil prices and bond yields marked minor reversals from upward trends earlier in the week, but investors are still watching both energy and bonds closely to see what long-term impact they might have on the stock market. Most attention centered on individual companies, some of which reported good news that sent their shares higher. Dell Technologies (NYSE:DVMT), Nektar Therapeutics (NASDAQ:NKTR), and Westport Fuel Systems (NASDAQ:WPRT) were among the best performers on the day. Here’s why they did so well.

  • [By Joseph Griffin]

    Westport Fuel Systems Inc (NASDAQ:WPRT) (TSE:WPRT) has earned an average rating of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $3.86.

Hot Clean Energy Stocks To Invest In 2019: Saia Inc.(SAIA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Saia (NASDAQ: SAIA) and ArcBest (NASDAQ:ARCB) are both transportation companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.

  • [By Stephan Byrd]

    Saia (NASDAQ:SAIA) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Tuesday.

  • [By Joseph Griffin]

    Verition Fund Management LLC bought a new stake in Saia Inc (NASDAQ:SAIA) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,872 shares of the transportation company’s stock, valued at approximately $441,000.

  • [By Max Byerly]

    State of Tennessee Treasury Department trimmed its holdings in Saia Inc (NASDAQ:SAIA) by 9.5% during the first quarter, HoldingsChannel.com reports. The fund owned 17,868 shares of the transportation company’s stock after selling 1,877 shares during the period. State of Tennessee Treasury Department’s holdings in Saia were worth $1,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Undervalued Stocks For 2018

Description of the opportunity and investment thesis

CRHM represents a compelling risk/reward opportunity in the form of a rapidly growing leader in anesthesiology services for GIs in the US and Canada. We believe the company is undervalued on an absolute and relative basis, currently trading at a dramatically low multiple of current and future estimated free cash flow. Given the companys niche position in their market, stable business model, long runway for growth, and fears surrounding short-term operational results, we feel weve been provided with a solid margin of safety at current price levels, with the chance for 100% upside or more within 12-18 months.

Top 5 Undervalued Stocks For 2018: Gladstone Investment Corporation(GAIN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    UGAIN (CURRENCY:GAIN) traded 7.5% lower against the U.S. dollar during the 24-hour period ending at 17:00 PM Eastern on May 26th. During the last week, UGAIN has traded down 25.8% against the U.S. dollar. UGAIN has a market cap of $0.00 and $37.00 worth of UGAIN was traded on exchanges in the last day. One UGAIN coin can now be purchased for about $0.0016 or 0.00000021 BTC on cryptocurrency exchanges including YoBit and CoinExchange.

  • [By Joseph Griffin]

    UGAIN (CURRENCY:GAIN) traded down 5.6% against the US dollar during the 1 day period ending at 15:00 PM Eastern on May 20th. Over the last week, UGAIN has traded down 9.7% against the US dollar. One UGAIN coin can now be bought for about $0.0020 or 0.00000024 BTC on exchanges including CoinExchange and YoBit. UGAIN has a market cap of $0.00 and $1,395.00 worth of UGAIN was traded on exchanges in the last day.

  • [By Taylor Cox]

    Investor Events

    Gladstone Capital Corporation (NASDAQ: GLAD) and Gladstone Investment Corporation (NASDAQ: GAIN) each holding an analyst/investor day
    Micron Technology, Inc (NASDAQ: MU) holding analyst/investor day
    Baxter International Inc (NYSE: BAX) investor conference

    Tuesday
    Notable Earnings

Top 5 Undervalued Stocks For 2018: Synnex Corporation(SNX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on SYNNEX (SNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Synnex (SNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Synnex (NYSE: SNX) and Presidio (NASDAQ:PSDO) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

  • [By Lee Jackson]

    This company flies somewhat under the radar, but it is way off its highs and offers a great entry point. SynnexCorp. (NYSE: SNX) is a business process services company that provides a range of distribution, logistics and integration services for the technology industry and providing outsourced services focused on customer engagement strategy.

Top 5 Undervalued Stocks For 2018: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

Top 5 Undervalued Stocks For 2018: Lockheed Martin Corporation(LMT)

Advisors’ Opinion:

  • [By ]

    Here are four names I like in the aerospace & defense group and why they look good right now.

    Lockheed Martin (LMT)

    As I wrote yesterday, Lockheed’ s older F-16 jet is considered a front runner in the Indian Air Force’s potential $15 billion order for 110 fighter aircraft. Lockheed also produces the more modern (and stealth capable) F-22, and F-35 fighters. Both of these fighters are professionally thought to be effective against Russia’s S-400 long range air defense missile system. That system is currently deployed in western Syria. Last week, Lockheed also won a $247 million contract from NASA to design and build an experimental aircraft that could operate without creating a traditional sonic boom. My price target: $375.

  • [By A.J. Bursick]

    And if relations between the United States and North Korea devolve to where they were just six short months ago, then the United States will need the likes of Boeing and Lockheed Martin Corp. (NYSE: LMT) to maintain our missile defense systems and to upgrade our outdated Minutemen ICBMs cache, which we only just started retesting thanks, no less, to North Korea’s ongoing threats.

  • [By ]

    The aviation and aerospace units at General Electric Co. (GE) and Honeywell International Inc. (HON) helped the two industrial giants beat earnings estimates, which bodes well for Lockheed Martin Corp. (LMT) and Boeing Co. (BA) as they prepare to report quarterly financial results next week.

  • [By Logan Wallace]

    Investors purchased shares of Lockheed Martin (NYSE:LMT) on weakness during trading on Friday. $92.09 million flowed into the stock on the tick-up and $57.96 million flowed out of the stock on the tick-down, for a money net flow of $34.13 million into the stock. Of all equities tracked, Lockheed Martin had the 28th highest net in-flow for the day. Lockheed Martin traded down ($0.45) for the day and closed at $324.04

  • [By ]

    Lockheed Martin Corp. (LMT)  fell Tuesday, April 24, after the defense contractor didn’t raise its free cash flow forecast even as the Trump administration spends more on defense.

  • [By ]

    Raytheon Co. (RTN) is well positioned to capitalize on missile orders given it has the highest exposure to missile defense and tactical missile sales to the Middle East, Bernstein said. Lockheed Martin Corp. (LMT) also stands to benefit in this light. 

Top 5 Undervalued Stocks For 2018: Motorola Solutions, Inc.(MSI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Qualcomm breaking even whilepotential peers Cisco Systems, Inc (NASDAQ: CSCO) and Motorola Solutions Inc (NYSE: MSI) have performed better with theirheir share of volatility:

Hot Warren Buffett Stocks To Own For 2018

Iconic billionaire Warren Buffett is sitting in the driver’s seat of a Buick SUV, talking to the drive-through cashier at a McDonald’s
MCD, -0.47%

Hot Warren Buffett Stocks To Own For 2018: MiMedx Group, Inc(MDXG)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap regenerative biomaterial product and bioimplant stock MiMedx Group Inc (NASDAQ: MDXG) is thethirteenth most shorted stock on theNASDAQ with short interest of 40.54% according to Highshortinterest.com. MiMedx Group isa leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing proprietary PURION庐 Process among other processes, to produce safe and effective allografts.MiMedx Group is the leading supplier of placental tissue, having supplied over 1,000,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

  • [By Paul Ausick]

    MiMedx Group Inc. (NASDAQ: MDXG) dropped nearly 23% Monday to post a new 52-week low of $6.05. Shares closed at $7.83 on Friday and the stock’s 52-week high is $18.25. Volume was over 22 million, about 10 times the daily average. The company postponed is quarterly report last week in order to conduct an accounting review and Bloomberg reported today that a U.S. Justice Department investigation is underway.

  • [By Garrett Baldwin]

    The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
    Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
    Four Stocks to Watch Today: BLK, FB, DAL
    Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
    The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
    Delta Air Lines Inc. (NYSE: DAL) reported ea

Hot Warren Buffett Stocks To Own For 2018: Boardwalk Pipeline Partners L.P.(BWP)

Advisors’ Opinion:

  • [By Tyler Crowe]

    Investors have been waiting for years for Boardwalk Pipeline Partners (NYSE:BWP) to fix the issues of debt and profitability that forced management to cut its payout. The path to repair these issues has been agonizingly slow, however, as Boardwalk posted another quarter of results that don’t suggest a return to a higher payout anytime soon.

  • [By WWW.GURUFOCUS.COM]

    For the details of Richmond Hill Investment Co., LP’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Richmond+Hill+Investment+Co.%2C+LP

    These are the top 5 holdings of Richmond Hill Investment Co., LPGlobal Indemnity Ltd (GBLI) – 1,043,157 shares, 52.79% of the total portfolio. Boardwalk Pipeline Partners LP (BWP) – 713,267 shares, 10.61% of the total portfolio. Shares added by 15.69%Post Holdings Inc (POST) – 85,288 shares, 9.47% of the total portfolio. Shares added by 112.95%Advance Auto Parts Inc (AAP) – 49,106 shares, 8.53% of the total portfolio. Shares reduced by 20.97%American International Group Inc (AIG.WS) – 320,761 shares, 7.71% of the

  • [By WWW.GURUFOCUS.COM]

    For the details of Richmond Hill Investment Co., LP’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Richmond+Hill+Investment+Co.%2C+LP

    These are the top 5 holdings of Richmond Hill Investment Co., LPGlobal Indemnity Ltd (GBLI) – 1,043,157 shares, 52.79% of the total portfolio. Boardwalk Pipeline Partners LP (BWP) – 713,267 shares, 10.61% of the total portfolio. Shares added by 15.69%Post Holdings Inc (POST) – 85,288 shares, 9.47% of the total portfolio. Shares added by 112.95%Advance Auto Parts Inc (AAP) – 49,106 shares, 8.53% of the total portfolio. Shares reduced by 20.97%American International Group Inc (AIG.WS) – 320,761 shares, 7.71% of the

  • [By WWW.GURUFOCUS.COM]

    For the details of Richmond Hill Investment Co., LP’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Richmond+Hill+Investment+Co.%2C+LP

    These are the top 5 holdings of Richmond Hill Investment Co., LPGlobal Indemnity Ltd (GBLI) – 1,043,157 shares, 52.79% of the total portfolio. Boardwalk Pipeline Partners LP (BWP) – 713,267 shares, 10.61% of the total portfolio. Shares added by 15.69%Post Holdings Inc (POST) – 85,288 shares, 9.47% of the total portfolio. Shares added by 112.95%Advance Auto Parts Inc (AAP) – 49,106 shares, 8.53% of the total portfolio. Shares reduced by 20.97%American International Group Inc (AIG.WS) – 320,761 shares, 7.71% of the

  • [By ]

    Boardwalk Pipeline Partners LP (NYSE: BWP) — While not directly tied to the price of oil due to its focus on the natural gas sector, Boardwalk does fall into the energy column. While the company’s revenue and EPS growth is lackluster and the yield (3.27%) is way below that of a typical energy MLP, the idea behind owning Boardwalk units is the deep discount of the actual assets of the company. The stock trades at just 50 cents on the dollar to the stated book value of the company and, as the company’s wheelhouse is storage and movement of natural gas and natural gas liquids (a now booming U.S. export business), real value will be unlocked. It’s just a matter of time.

Hot Warren Buffett Stocks To Own For 2018: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Investment Technology Group (NYSE:ITG) announced a quarterly dividend on Thursday, May 17th, RTT News reports. Investors of record on Wednesday, May 30th will be given a dividend of 0.07 per share by the financial services provider on Friday, June 15th. This represents a $0.28 dividend on an annualized basis and a yield of 1.23%.

Hot Warren Buffett Stocks To Own For 2018: Acacia Research Corporation(ACTG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Stephan Byrd]

    ValuEngine lowered shares of Acacia Research (NASDAQ:ACTG) from a buy rating to a hold rating in a report published on Wednesday morning.

    ACTG has been the topic of a number of other reports. Zacks Investment Research downgraded shares of Acacia Research from a buy rating to a hold rating in a report on Friday, March 23rd. TheStreet downgraded shares of Acacia Research from a c- rating to a d rating in a report on Friday, February 16th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $5.67.

Hot Warren Buffett Stocks To Own For 2018: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

Hot Warren Buffett Stocks To Own For 2018: Insperity, Inc.(NSP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Insperity (NSP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks For 2018

Prabhudas Lilladher’s research report on Dabur India

Dabur has shown 7.7% domestic volume growth on a low base led by market share gains in most segments. Dabur is aiming for 8-10% volume growth in 1H19 which can increase to double digit in 2H19 depending upon monsoons. Gross margins are unlikely to expand, however better profitability in IBD and operating leverage in domestic business will provide moderate margin expansion. Dabur expects GST e-way bill led trade disruptions in 1Q however overall demand scenario looks optimistic.

Outlook

We estimate 16% PAT CAGR over FY18-20. We value Dabur at 35xFY20 EPS and arrive at target price of Rs377. We expect back ended returns post 32% upmove in last 1 year. Maintain “Accumulate”.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Hot Value Stocks For 2018: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

Hot Value Stocks For 2018: Range Resources Corporation(RRC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) fell about 4.4% Tuesday to post a new 52-week low of $14.43 after closing at $15.09 on Monday. The 52-week high is $34.93. Volume of about 15 million was nearly double the daily average of around 7.7 million shares traded. The company had no specific news.

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) fell about 3.6% Monday to post a new 52-week low of $14.77 after closing at $15.30 on Friday. The 52-week high is $35.64. Volume of about 9.4 million was about 20% higher than the daily average of around 7.7 million shares traded. The company had no specific news.

Hot Value Stocks For 2018: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Best Value Stocks To Own For 2018

Top executives at United Parcel Service Inc. (NYSE: UPS) took home outrageously high compensation last year, even though the parcel carrier missed many of its performance targets, like revenue growth and total shareholder returns.

In fact, UPS said in its March filings with the U.S. Securities and Exchange Commission (SEC) its three-year performance missed targets for revenue growth, operating return on invested capital, and total shareholder returns.

Even worse, the world’s largest package delivery company also missed some of its financial targets for 2016. For example, UPS’s net income fell 29% last year after it struggled to handle the rising costs of e-commerce.

Yet UPS CEO David Abney earned a surprising 21% more in total compensation in 2016 than the prior year, according to the new SEC filings. Abney took in a whopping $13.7 million, including a salary of $1.1 million (a 6.3% increase), stock awards of $10.2 million (a 22% increase), and long-term awards valued at $860,000.

Best Value Stocks To Own For 2018: The NASDAQ OMX Group Inc.(NDAQ)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Joseph Griffin]

    ILLEGAL ACTIVITY NOTICE: “$644.24 Million in Sales Expected for Nasdaq Inc (NDAQ) This Quarter” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3374974/644-24-million-in-sales-expected-for-nasdaq-inc-ndaq-this-quarter.html.

  • [By ]

    There’s at least one traditional financial giant that not only doesn’t fear blockchain technology, but is actively embracing it — Nasdaq (NDAQ) , the second-largest stock exchange in the world by market cap.

  • [By Asit Sharma]

    In its last sequential quarter, Nasdaq Inc.(NASDAQ:NDAQ)relied on non-trading segments for growth as its market-services segment turned in a near flat performance. In the first quarter of 2018, however, healthy trading volumes resumed, and Nasdaq achieved expansion in each of its four operating segments. Before sifting through important highlights for the quarter, let’s briefly review the top-level performance:

  • [By Wayne Duggan]

    Nasdaq Inc (NASDAQ: NDAQ) CEO Adena Friedman told CNBC the company is open to the possibility of adding a cryptocurrency exchange over time. Nasdaq also announced a deal to allow cryptocurrency exchange Gemini access to Nasdaq’s surveillance technology. Friedman told CNBC that cryptocurrency regulations must first be ironed out before the Nasdaq would add a crypto exchange.

Best Value Stocks To Own For 2018: Horizon Global Corporation(HZN)

Advisors’ Opinion:

  • [By Brian Feroldi]

    Horizon Global(NYSE:HZN)reported its first-quarter results on May 3. The provider ofbranded towing and trailering equipment had already warned investors that it was going through tough times but promised that it would take action to fix its problems.Let’s dig into the company’s results to see if those actions are starting to pay off.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Horizon Global (NYSE:HZN) has earned an average rating of “Hold” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $15.08.

Best Value Stocks To Own For 2018: First Cash Financial Services, Inc.(FCFS)

Advisors’ Opinion:

  • [By Logan Wallace]

    First Cash Financial Services, Inc. (NYSE:FCFS) shares hit a new 52-week high and low during trading on Thursday . The company traded as low as $88.95 and last traded at $88.70, with a volume of 371494 shares traded. The stock had previously closed at $87.80.

Best Value Stocks To Own For 2018: Palo Alto Networks, Inc.(PANW)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    The cybersecurity industry is growing, but FireEye’s product is viewed as more of an add-on to a company’s existing threat-detection system rather than a comprehensive plan. As a result, some of its larger peers like Palo Alto Networks (NYSE:PANW), Juniper Networks (NYSE:JNPR), and tech giant Cisco (NASDAQ:CSCO) have fared much better the last few years. In response to its slowdown, FireEye has begun offeringadditional services and features to create a more well-rounded menu for its customers.

  • [By Chris Lange]

    Palo Alto Networks Inc.’s (NYSE: PANW) fiscal second-quarter report is scheduled for Monday. The consensus estimates are calling for $0.79 in earnings per share (EPS) on $524.82 million in revenue. The shares traded on Fridays close at $165.54. The consensus price target is $173.27, and the 52-week trading range is $107.31 to $167.73.

  • [By Harsh Chauhan]

    Pure-play cybersecurity specialist Palo Alto Networks (NYSE:PANW) has done well to carve a strong position in this market, recording impressive revenue growth over the years.

  • [By ]

    Cybersecurity remains red hot, after another three high-profile attacks, at Under Armour (UAA) , Boeing (BA) and Hudson’s Bay, the parent of Saks. But while many investors know of the big boys like Palo Alto Networks (PANW) , Fortinet (FTNT) and Proofpoint (PFPT) , Cramer dove into three smaller cybersecurity names to see if they’re worth investing in.

  • [By ]

    From the outside looking in, it seems as if a lack of focus could be hurting Symantec. The company’s security product line is enormous, covering everything from gateways to e-mail encryption to malware analysis to forensics to risk analytics. This puts Symantec in competition with many security pure-plays that have been growing rapidly (think Palo Alto Networks (PANW) or Proofpoint (PFPT) ), as well as IT giants who have made growing security sales a major priority (think IBM  (IBM) or Cisco Systems (CSCO) ).

Best Value Stocks To Own For 2018: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

Best Medical Stocks To Buy For 2019

CEO & President of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Mark Pruzanski bought 7,812 shares of ICPT on 04/09/2018 at an average price of $64 a share. The total cost of this purchase was $499,968.

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need. Intercept Pharmaceuticals Inc has a market cap of $1.74 billion; its shares were traded at around $69.24 with and P/S ratio of 13.47.

CEO Recent Trades:

CEO & President Mark Pruzanski bought 7,812 shares of ICPT stock on 04/09/2018 at the average price of $64. The price of the stock has increased by 8.19% since.

Directors and Officers Recent Trades:

10% Owner S.p.a. Genextra bought 390,625 shares of ICPT stock on 04/09/2018 at the average price of $64. The price of the stock has increased by 8.19% since.10% Owner Francesco Micheli bought 390,625 shares of ICPT stock on 04/09/2018 at the average price of $64. The price of the stock has increased by 8.19% since.Director Keith Michael Gottesdiener bought 1,171 shares of ICPT stock on 04/09/2018 at the average price of $64. The price of the stock has increased by 8.19% since.Director Daniel Bradbury bought 7,812 shares of ICPT stock on 04/09/2018 at the average price of $64. The price of the stock has increased by 8.19% since.

For the complete insider trading history of ICPT, click here

Best Medical Stocks To Buy For 2019: CryoLife, Inc.(CRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CryoLife (NYSE:CRY) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.29-0.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.31. The company issued revenue guidance of $250-256 million, compared to the consensus revenue estimate of $252.86 million.

Best Medical Stocks To Buy For 2019: Cadence Design Systems, Inc.(CDNS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Motley Fool Staff]

    Cadence Design Systems (NASDAQ:CDNS) Q1 2018 Earnings Conference CallApril 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7
  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D
  • [By Garrett Baldwin]

    Southwest Airlines Inc. (NYSE: LUV) canceled flights across the country in order to inspect the engines of 40 different airplanes. The inspections come a week after a mid-air engine explosion caused the first U.S. air fatality since 2009. Money Morning Executive Editor Bill Patalon breaks down the aftermath of the accident, and explains what it means for both Southwest and Boeing Co. (NYSE: BA).
    The price of Bitcoin pushed back toward $9,000 as the post-tax season breakout continues for the cryptocurrency markets. The total value of the global cryptocurrency market topped $400 billion this morning, a significant recovery from the massive downturn that occurred in the first quarter. As we explained on Saturday, now may be the best time to buy Bitcoin since July 2013. That month was when Money MorningDefense and Tech Specialist Michael A. Robinson went on live television with a bold prediction forBitcoin (BTC), which would be followed by 25,351% gains at the peak of the cryptocurrency’s run. Find out where Bitcoin is heading next, right here.
    Three Stocks to Watch Today: GOOGL, LUV, HAS
    Alphabet Inc. (Nasdaq: GOOGL) leads another busy day of earnings reports on Monday. Wall Street anticipates that the online media giant will report earnings per share (EPS) of $9.21 on top of $24.29 billion in revenue.
    Hasbro Inc. (NYSE: HAS) slumped more than 7.6% in pre-market hours after the company reported earnings. The toymaker reported adjusted EPS of $0.10, well short of the $0.33 expected on Wall Street. The firm also reported weaker-than-expected revenue for the quarter. The firm named Toys ‘R Us as a central reason for poor showing – the company recently liquidated its stores, impacting Hasbro Inc.’s (Nasdaq: HAS) bottom lines.
    Look for earnings reports from Halliburton Co.(NYSE: HAL), Alaska Air Group Inc.(NYSE: ALK), Whirlpool Corp. (NYSE: WHR), TD Ameritrade Holding Corp. (Nasdaq: AMTD), Kimberley-Clark Corp. (NYSE: KMB), Cadence Design Syst

Best Medical Stocks To Buy For 2019: Tree.com Inc.(TREE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market climbed sharply on Thursday, responding well to favorable earnings results from several corners of the market. Major benchmarks were up 1% to 2%, with particularly good performance from the Nasdaq Composite thanks to the tech sector’s outperformance during the day. Yet some stocks suffered from bad news that cast doubt on companies’ ability to benefit from generally favorable business conditions. MGM Resorts International (NYSE:MGM), Arch Coal (NYSE:ARCH), and LendingTree (NASDAQ:TREE) were among the worst performers on the day. Here’s why they did so poorly.

Best Medical Stocks To Buy For 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

Best Medical Stocks To Buy For 2019: Time Warner Inc.(TWX)

Advisors’ Opinion:

  • [By Max Byerly]

    Sheaff Brock Investment Advisors LLC raised its position in Time Warner (NYSE:TWX) by 11.2% during the first quarter, according to its most recent filing with the SEC. The firm owned 5,978 shares of the media conglomerate’s stock after purchasing an additional 601 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in Time Warner were worth $565,000 as of its most recent filing with the SEC.

  • [By ]

    The Justice suit to block AT&T Inc.’s (T) acquisition of Time Warner Inc. (TWX) can be attributed at least in part to politics, as Trump has made no secret of his disdain for CNN. There are other signs of the administration’s aggressiveness on antitrust, however. In December, the DOJ pushed Parker-Hannifin to divest a business it already acquired from Clarcor Inc. in February 2017. 

  • [By ]

    The combination of less content from major competitor Disney (DIS) , which will be pulling the majority of its newer content from Netflix at the end of 2018, and others such as Time Warner (TWX) and Fox (FOX) moving toward exclusive deals with services like Hulu will cause some subscriber dissatisfaction, Pachter wrote.

Best Stocks To Invest In 2018

Filipino tourists take a "selfie" photograph on the beach on Pandan island, Palawan, the Philippines on Thursday, June 25, 2015. Photographer: Sanjit Das/Bloomberg

Its 2017, and the FOMO (fear of missing out) is real. Luckily, social media is around to capture every moment. Every time you log on to Facebook, you see Janet, an acquaintance from high school, and she just updated her photo album with pictures from her latest adventure to San Francisco. Instagram and Twitter arent much better. On Insta, you see shot after shot of Mark, the guy who sat behind you in Economics 101, proposing to his girlfriend at the beach while Twitter rolled out 140 more characters so your cousin Sam can tweet about how much she OMG LOVES her new job twice as much.

Best Stocks To Invest In 2018: CSX Corporation(CSX)

Advisors’ Opinion:

  • [By ]

    CSX Corp. (CSX) shares rose slightly ahead of its first-quarter financial results, which will be released after the bell Tuesday, April 17.

  • [By Ethan Ryder]

    CSX Co. (NASDAQ:CSX) CEO James M. Foote bought 5,000 shares of the firm’s stock in a transaction on Wednesday, May 2nd. The stock was acquired at an average price of $59.91 per share, for a total transaction of $299,550.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By ]

    Railroad CSX (CSX) is another stealth tech company. CSX saw its load volumes decrease this quarter, but was still able to crush earnings estimates thanks to increased efficiencies that stemmed from — you guessed it — technology. Shares of CSX were up 7.8% on the day.

  • [By Garrett Baldwin]

    Market fears of an escalating Middle Eastern conflict abated thanks to last week’s military strikes against the Syrian government. On Friday, April 13, U.S. forces joined the United Kingdom and France in retaliation for a chemical gas attack carried out by the Syrian government. The military exercise came at a time that tensions are also rising in the Middle East between Saudi Arabia and Iran.
    Today, several members of the U.S. Federal Reserve will be speaking at events around the globe, including San Francisco Fed President John Williams and Chicago Fed Bank President Charles Evans. But no one will be more watched today than Fed Gov. Randal Quarles, who will testify before the U.S. House Financial Services Commission. Quarles will provide testimony on the central bank’s plans to regulate and oversee the financial system. Expect a wealth of questions about the Fed’s plans to raise interest rates and manage its massive balance sheet. Money MorningLiquidity SpecialistLee Adler offers you advice on how to play the Fed’s problems, right here.
    Four Stocks to Watch Today: GS, NFLX, TSLA, and ROKU
    Shares of Goldman Sachs Group Inc. (NYSE: GS) added 0.6% after the Wall Street bank easily topped Q1 earnings and revenue estimates. The firm reportedearnings per share (EPS) of $6.95 on top of more than $10 billion in revenue. Analysts projected EPS of $5.67 on top of $8.89 billion. The investment bank hiked its quarterly dividend and said that revenue from equity trading rallied thanks to an uptick in recent market volatility.
    Shares of Tesla Inc. (Nasdaq: TSLA) are flat on the news that the firm will suspend production of its Model 3 vehicles. The firm said the temporary halt in production will aim to “improve automation” and address ongoing bottlenecks in its production process.
    Shares of Roku Inc. (Nasdaq: ROKU) popped more than 8.2% on news that Steven Cohen’s family office has taken a passive 5.1% stake in the company. The streaming device manufactur

  • [By Motley Fool Staff]

    In this segment from theMarketFoolery podcast, host Chris Hill and Motley Fool Asset Management’s Bill Barker take a gander at the results from freight railroad giant CSX (NASDAQ:CSX), which earned almost $700 million in its first quarter — a huge beat relative to expectations, with bottom-line growth of more than 50% annually.

  • [By Asit Sharma]

    It also hasn’t helped that competitorCSX Corporation (NASDAQ:CSX) just reported a massive year-over-year jump of nearly 6 percentage points in its operating ratio, from 69.4% to 63.7%, in the first quarter of 2018.I recently described how a more aggressive approach to operations appears to be fueling CSX’s productivity. And yet it should be acknowledged that CSX isn’t facing a congestion event like Union Pacific’s.

Best Stocks To Invest In 2018: Performant Financial Corporation(PFMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Performant Financial Corporation (NASDAQ: PFMT) were down 29 percent to $2.20. Performant Financial is expected to release Q1 earnings on May 8.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

Best Stocks To Invest In 2018: Macatawa Bank Corporation(MCBC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Macatawa Bank (NASDAQ:MCBC) from a buy rating to a strong-buy rating in a research note released on Friday morning.

    Separately, Hovde Group set a $11.00 price target on Macatawa Bank and gave the stock a hold rating in a research report on Monday, January 29th.

Best Stocks To Invest In 2018: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

Best Stocks To Invest In 2018: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

Best Stocks To Invest In 2018: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Rockwell Automation (NYSE: ROK) and Oxford Instruments (OTCMKTS:OXINF) are both industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI

Top 5 Stocks To Watch Right Now

AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Michael Marberry also recently made the following trade(s):

Get AdvanSix alerts:

On Thursday, April 12th, Michael Marberry bought 714 shares of AdvanSix stock. The stock was purchased at an average price of $34.95 per share, for a total transaction of $24,954.30. On Friday, April 6th, Michael Marberry bought 685 shares of AdvanSix stock. The stock was purchased at an average price of $36.50 per share, for a total transaction of $25,002.50. On Friday, March 23rd, Michael Marberry bought 715 shares of AdvanSix stock. The stock was purchased at an average price of $34.97 per share, for a total transaction of $25,003.55. On Thursday, March 8th, Michael Marberry bought 574 shares of AdvanSix stock. The stock was purchased at an average price of $43.51 per share, for a total transaction of $24,974.74.

Shares of ASIX traded up $0.82 during trading hours on Tuesday, hitting $35.12. 286,561 shares of the company were exchanged, compared to its average volume of 306,404. The company has a market cap of $1.11 billion, a PE ratio of 11.71 and a beta of 1.44. AdvanSix has a 52 week low of $26.54 and a 52 week high of $46.51. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.72 and a current ratio of 1.17.

Top 5 Stocks To Watch Right Now: Euro Tech Holdings Company Limited(CLWT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
    China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
    Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
    Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
    Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
    Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
    Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
    Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
    Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
    Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
    HMS Holdings Corp (NASDAQ: H
  • [By Money Morning News Team]

    However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we’ll show you a small-cap stock with serious profit potential in its future…

    Penny Stock Current Share Price Law Week’s Gain
    VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57%
    Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11%
    Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38%
    Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92%
    Vivis Inc. (Nasdaq: VVUS) $0.52 38.82%
    HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49%
    Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23%
    Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19%
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)

Top 5 Stocks To Watch Right Now: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Logan Wallace]

    Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

Top 5 Stocks To Watch Right Now: CA Inc.(CA)

Advisors’ Opinion:

  • [By Shane Hupp]

    CA Technologies (NASDAQ:CA) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.75-$2.81 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.74. The company issued revenue guidance of $4.25-$4.29 billion, compared to the consensus revenue estimate of $4.31 billion.

  • [By Joseph Griffin]

    CA Technologies (NASDAQ:CA) – Equities researchers at Oppenheimer issued their Q1 2019 earnings estimates for CA Technologies in a research note issued to investors on Wednesday, May 9th. Oppenheimer analyst S. Eyal expects that the technology company will earn $0.62 per share for the quarter. Oppenheimer currently has a “Hold” rating on the stock. Oppenheimer also issued estimates for CA Technologies’ Q2 2019 earnings at $0.66 EPS, Q3 2019 earnings at $0.68 EPS, Q4 2019 earnings at $0.62 EPS and FY2020 earnings at $2.68 EPS.

  • [By ]

    CA, Inc. (Nasdaq: CA)
    Known in a former life as Computer Associates, CA is the biggest software company you’ve never heard of. With a market cap of $13.8 billion and annual revenues in excess of $4 billion, CA provides enterprise software solutions focusing on mainframe platforms, enterprise environments, database security operations, and cloud applications.

Top 5 Stocks To Watch Right Now: Unilever N.V. (UNLVF)

Advisors’ Opinion:

  • [By ]

    In recent weeks, Procter & Gamble (PG) has received a couple of downgrades following its Q3 FY2018 results announcement. In contrast, its peer in the consumer products space, Unilever (UL)(UN)(OTCPK:UNLNF)(OTCPK:UNLYF)(OTCPK:UNLVF), was upgraded by UBS in late March. Investors also cheered the announcement of a fresh 6 billion ($7.4 billion) stock buyback program and the raising of its quarterly dividend by 8% to 0.3872/share from 0.3585. In 2017, Unilever has already completed a 5 billion share buyback programme.

Top 5 Stocks To Watch Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile